# Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application

> **NCT00621114** · NA · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 69 (actual)

## Conditions studied

- Hemodialysis

## Interventions

- **DEVICE:** GamCath® central venous catheter
- **DEVICE:** GamCath Dolphin® Protect central venous catheter

## Key facts

- **NCT ID:** NCT00621114
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621114, "Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00621114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*